SCR Pharmatop's IV Paracetamol Patent Gets Revoked by the IPO

in #pharmapatent3 years ago

In a landmark decision, the Indian Patent Office has decided in favor of Venus Remedies with regards to a matter concerning the IV Paracetamol patent. Venus Remedies had challenged SCR Pharmatop’s patent citing that the patent did not comprise of any inventive step. Read more: https://bit.ly/3DIyIGy

Indian-Patent-Office-revokes-SCR-Pharmatop’s-IV-paracetamol-patent-Decides-in-favour-of-Venus-Remedies.jpg

Coin Marketplace

STEEM 0.16
TRX 0.17
JST 0.030
BTC 70594.76
ETH 2525.57
USDT 1.00
SBD 2.56